Fibroblast Growth Factor 2-Mediated Translational Control of IAPs Blocks Mitochondrial Release of Smac/DIABLO and Apoptosis in Small Cell Lung Cancer Cells

Molecular and Cellular Biology

Volumn 23, Issue 21, 2003, Pages 7600-7610

  Pardo, Olivier E ^a   Lesay, Adeline ^b   Arcaro, Alexandre ^a   Lopes, Rita ^a   Ng, Bee Ling ^a   Warne, Patricia H ^a   McNeish, Iain A ^a   Tetley, Teresa D ^c   Lemoine, Nicholas R ^a   Mehmet, Huseyin ^b   Seckl, Michael J ^a,b   Downward, Julian ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CYTOCHROME C; ETOPOSIDE; FIBROBLAST GROWTH FACTOR 2; INHIBITOR OF APOPTOSIS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; TRANSLATION REGULATION;

APOPTOSIS; CARCINOMA, SMALL CELL; CARRIER PROTEINS; CASPASES; CELL DEATH; CELL LINE, TUMOR; CULTURE MEDIA, SERUM-FREE; CYTOCHROMES C; ENZYME ACTIVATION; ETOPOSIDE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE KINASE 1; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NUCLEIC ACID SYNTHESIS INHIBITORS; PROTEIN BIOSYNTHESIS; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

INTRACISTERNAL A-PARTICLES;

EID: 10744226583     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.21.7600-7610.2003     Document Type: Article

References (46)

1. Acehan, D., X. Jiang, D. G. Morgan, J. E. Heuser, X. Wang, and C. W. Akey. 2002. Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol. Cell 9:423-432.
2. Adrain, C., E. M. Creagh, and S. J. Martin. 2001. Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J. 20:6627-6636.
3. Arnt, C. R., M. V. Chiorean, M. P. Heldebrant, G. J. Gores, and S. H. Kaufmann. 2002. Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAPI in situ. J. Biol. Chem. 277:44236-44243.
4. Bennett, M. R., and J. J. Boyle. 1998. Apoptosis of vascular smooth muscle cells in atherosclerosis. Atherosclerosis 138:3-9.
5. Borg, A. G., R. Burgess, L. M. Green, R. J. Scheper, and J. A. Yin. 1998. Overexpression of lung-resistance protein and increased P-glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival. Br. J. Haematol. 103:1083-1091.
6. Bratton, S. B., G. Walker, S. M. Srinivasula, X. M. Sun, M. Butterworth, E. S. Alnemri, and G. M. Cohen. 2001. Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J. 20:998-1009.
7. Brazil, D. P., and B. A. Hemmings. 2001. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26:657-664.
8. Brill, A., A. Torchinsky, H. Carp, and V. Toder. 1999. The role of apoptosis in normal and abnormal embryonic development. J. Assist. Reprod. Genet. 16:512-519.
9. Chai, J., C. Du, J. W. Wu, S. Kyin, X. Wang, and Y. Shi. 2000. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 406: 855-862.
10. Chauhan, D., T. Hideshima, S. Rosen, J. C. Reed, S. Kharbanda, and K. C. Anderson. 2001. Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells. J. Biol. Chem. 276: 24453-24456.
11. Cole, S. P., and R. G. Deeley. 1996. Multidrug resistance associated with overexpression of MRP. Cancer Treat. Res. 87:39-62.
12. Cordon-Cardo, C., I. Vlodavsky, A. Haimovitz-Friedman, D. Hicklin, and Z. Fuks. 1990. Expression of basic fibroblast growth factor in normal human tissues. Lab. Investig. 63:832-840.
13. DeLong, M. J. 1998. Apoptosis: a modulator of cellular homeostasis and disease states. Ann. N. Y. Acad. Sci. 842:82-90.
14. Deng, Y., Y. Lin, and X. Wu. 2002. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev. 16:33-45.
15. Deveraux, Q. L., and J. C. Reed. 1999. IAP family proteins-suppressors of apoptosis. Genes Dev. 13:239-252.
16. Du, C., M. Fang, Y. Li, L. Li, and X. Wang. 2000. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33-42.
17. Erhardt, P., E. J. Schremser, and G. M. Cooper. 1999. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway. Mol. Cell. Biol. 19:5308-5315.
18. Fulda, S., W. Wick, M. Weller, and K. M. Debatin. 2002. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat. Med. 8:808-815.
19. Hegde, R., S. M. Srinivasula, Z. Zhang, R. Wassell, R. Mukattash, L. Cilenti, G. DuBois, Y. Lazebnik, A. S. Zervos, T. Fernandes-Alnemri, and E. S. Alnemri. 2002. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem. 277:432-438.
20. Hu, S., and X. Yang. 2003. Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J. Biol. Chem. 278:10055-10060.
21. Kluck, R. M., E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136.
22. Laupeze, B., L. Amiot, B. Drenou, M. Bernard, B. Branger, J. M. Grosset, T. Lamy, R. Fauchet, and O. Fardel. 2002. High multidrug resistance protein activity in acute myeloid leukaemias is associated with poor response to chemotherapy and reduced patient survival. Br. J. Haematol. 116:834-838.
23. Lawlor, M. A., and D. R. Alessi. 2001. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J. Cell Sci. 114:2903-2910.
24. Liu, J. R., A. W. Opipari, L. Tan, Y. Jiang, Y. Zhang, H. Tang, and G. Nunez. 2002. Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. Cancer Res. 62:924-931.
25. MacFarlane, M., W. Merrison, S. B. Bratton, and G. M. Cohen. 2002. Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. J. Biol. Chem. 277:36611-36616.
26. Martins, L. M., I. Iaccarino, T. Tenev, S. Gschmeissner, N. F. Totty, N. R. Lemoine, J. Savopoulos, C. W. Gray, C. L. Creasy, C. Dingwall, and J. Downward. 2002. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J. Biol. Chem. 277:439-444.
27. Miyake, H., I. Hara, Y. Gohji, K. Yoshimura, S. Arakawa, and S. Kamidono. 1998. Expression of basic fibroblast growth factor is associated with resistance to cisplatin in a human bladder cancer cell line. Cancer Lett. 123:121-126.
28. Noda, K., Y. Nishiwaki, M. Kawahara, S. Negoro, T. Sugiura, A. Yokoyama, M. Fukuoka, K. Mori, K. Watanabe, T. Tamura, S. Yamamoto, and N. Saijo. 2002. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N. Engl. J. Med. 346:85-91.
29. Okada, H., W. K. Suh, J. Jin, M. Woo, C. Du, A. Elia, G. S. Duncan, A. Wakeham, A. Itie, S. W. Lowe, X. Wang, and T. W. Mak. 2002. Generation and characterization of Smac/DIABLO-deficient mice. Mol. Cell. Biol. 22: 3509-3517.
30. Pardo, O. E., A. Arcaro, G. Salerno, S. Raguz, J. Downward, and M. J. Seckl. 2002. Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway: correlation with resistance to etoposide-induced apoptosis. J. Biol. Chem. 277:12040-12046.
31. Pardo, O. E., A. Arcaro, G. Salerno, T. D. Tetley, T. Valovka, I. Gout, and M. J. Seckl. 2001. Novel cross talk between MEK and S6K2 in FGF-2 induced proliferation of SCLC cells. Oncogene 20:7658-7667.
32. Salvesen, G. S., and M. Renatus. 2002. Apoptosome: the seven-spoked death machine. Dev. Cell 2:256-257.
33. Schulze, A., K. Lehmann, H. B. Jefferies, M. McMahon, and J. Downward. 2001. Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev. 15:981-994.
34. Shi, Y. 2002. Apoptosome: the cellular engine for the activation of caspase-9. Structure (Cambridge) 10:285-288.
35. Slee, E. A., M. T. Harte, R. M. Kluck, B. B. Wolf, C. A. Casiano, D. D. Newmeyer, H. G. Wang, J. C. Reed, D. W. Nicholson, E. S. Alnemri, D. R. Green, and S. J. Martin. 1999. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144:281-292.
36. Song, S., M. G. Wientjes, Y. Gan, and J. L. Au. 2000. Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs. Proc. Natl. Acad. Sci. USA 97:8658-8663.
37. Srinivasula, S. M., R. Hegde, A. Saleh, P. Datta, E. Shiozaki, J. Chai, R. A. Lee, P. D. Robbins, T. Fernandes-Alnemri, Y. Shi, and E. S. Alnemri. 2001. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410:112-116.
38. Sun, X. M., S. B. Bratton, M. Butterworth, M. MacFarlane, and G. M. Cohen. 2002. Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein. J. Biol. Chem. 277:11345-11351.
39. Suzuki, Y., Y. Imai, H. Nakayama, K. Takahashi, K. Takio, and R. Takahashi. 2001. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell 8:613-621.
40. Tashker, J. S., M. Olson, and S. Kornbluth. 2002. Post-cytochrome c protection from apoptosis conferred by a MAPK pathway in Xenopus egg extracts. Mol. Biol. Cell 13:393-401.
41. van Loo, G., X. Saelens, M. van Gurp, M. MacFarlane, S. J. Martin, and P. Vandenabeele. 2002. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ. 9:1031-1042.
42. Verhagen, A. M., P. G. Ekert, M. Pakusch, J. Silke, L. M. Connolly, G. E. Reid, R. L. Moritz, R. J. Simpson, and D. L. Vaux. 2000. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102:43-53.
43. Verhagen, A. M., and D. L. Vaux. 2002. Cell death regulation by the mammalian IAP antagonist Diablo/Smac. Apoptosis 7:163-166.
44. Villa, P., S. H. Kaufmann, and W. C. Earnshaw. 1997. Caspases and caspase inhibitors. Trends Biochem. Sci. 22:388-393.
45. Witherden, I., and T. Tetley. 2001. Isolation and culture of human alveolar type II pneumocytes. Methods Mol. Med. 56:137-146.
46. Yang, J., X. Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T. I. Peng, D. P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-1132.